TALK: How to deal with section 3d of the Indian Patent Act: Risks and opportunities – University of Copenhagen

Center for Synthetic Biology > News > TALK: How to deal with...

17 September 2015

TALK: How to deal with section 3d of the Indian Patent Act: Risks and opportunities

SEMINAR

Timo Minssen speaks at "Innovation vs Replication: Can IPR be safeguarded in India?

Abstract

This presentation will discuss the Indian Supreme Court's decision in the Novartis/Gleevec case concerning the Constitutional validity and scope of Sec. 3(d) of the Indian Patents Act. This case has clarified the legislative intent behind various key provisions in the Indian Patents Act. It also raises crucial issues regarding India's compliance with TRIPS and the patentability of formulation inventions. The main objective of this session is to analyze the background and practical impact of this decision in order to identify challenges and opportunities for companies entering the Indian market.

Time: 18 September 2015, 10:20-11:00

Place: Faculty of Law, University of Copenhagen, Studiegaarden, Studiestraede 6, DK-1455 Copenhagen K

Organizer: Innovation Centre Denmark, New Dehli, Bangalore. University of Copenhagen. Bio People.

Sign up here